Quick Answer
EXOZYMES INC. reported Net Income of -$9.16 million for fiscal year 2025.
EXOZYMES INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$9.16M | -56.3% |
| 2024 | -$5.86M | -187.5% |
| 2023 | -$2.04M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.29M | -38.1% | +3.1% |
| June 30, 2025 | -$2.36M | -73.5% | -27.1% |
| March 31, 2025 | -$1.86M | -84.1% | -12.1% |
| September 30, 2024 | -$1.66M | -218.2% | -21.7% |
| June 30, 2024 | -$1.36M | -664.0% | -34.9% |
| March 31, 2024 | -$1.01M | -318.2% | -93.7% |
| September 30, 2023 | -$520.6K | — | -192.3% |
| June 30, 2023 | -$178.1K | — | +26.2% |
- EXOZYMES INC. showed a decrease of -56.3% in Net Income compared to the prior fiscal year.
- Over the 2023–2025 period, EXOZYMES INC.’s net income has declined by 349.3% (from -$2.04 million to -$9.16 million).
- The most recent figure is from EXOZYMES INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: